NeuroSentry
NeuroSentry focuses on developing technology-driven solutions for real-time in-hospital stroke detection, addressing a critical clinical gap in perioperative and hospitalized patient care. Their work leverages quantitative EEG methods to enable rapid recognition and intervention for brain injury with the goal of improving outcomes following high-risk surgical procedures.
What We Do
Quantitative EEG-based index designed to enable real-time detection of stroke and cerebral ischemia for in-hospital use by non-experts.
Quantitative EEG-based index designed to enable real-time detection of stroke and cerebral ischemia for in-hospital use by non-experts.
Application Area
Digital Health Technologies
Key People
News & Updates
Dr. Mauro Caffarelli recognized as a 2025 Catalyst awardee for translational innovation with clinical and commercial impact.
NeuroSentry selected to join the NSF National ICORPS program, receiving non-dilutive funding for customer discovery.
NeuroSentry was admitted to the California Life Sciences FAST cohort to support early-stage startups with mentorship and advisory connections.
Dr. Mauro Caffarelli recognized as a 2025 Catalyst awardee for translational innovation with clinical and commercial impact.
NeuroSentry selected to join the NSF National ICORPS program, receiving non-dilutive funding for customer discovery.
NeuroSentry was admitted to the California Life Sciences FAST cohort to support early-stage startups with mentorship and advisory connections.